zardaverine has been researched along with Experimental Lung Inflammation in 1 studies
zardaverine: structure given in first source
zardaverine : A pyridazinone derivative in which pyridazin-3(2H)-one is substituted at C-6 with a 4-(difluoromethoxy)-3-methoxyphenyl group. It is a phosphodiesterase inhibitor, selective for PDE3 and 4.
Experimental Lung Inflammation: Inflammation of any part, segment or lobe, of the lung parenchyma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kümmerle, AE | 1 |
| Schmitt, M | 1 |
| Cardozo, SV | 1 |
| Lugnier, C | 1 |
| Villa, P | 1 |
| Lopes, AB | 1 |
| Romeiro, NC | 1 |
| Justiniano, H | 1 |
| Martins, MA | 1 |
| Fraga, CA | 1 |
| Bourguignon, JJ | 1 |
| Barreiro, EJ | 1 |
1 other study available for zardaverine and Experimental Lung Inflammation
| Article | Year |
|---|---|
Design, synthesis, and pharmacological evaluation of N-acylhydrazones and novel conformationally constrained compounds as selective and potent orally active phosphodiesterase-4 inhibitors.
Topics: Administration, Oral; Animals; Drug Design; Female; Humans; Hydrazones; Magnetic Resonance Spectrosc | 2012 |